Pune has a developed healthcare environment supported by hospitals, specialist clinics, pharmacies, eye-care professionals and pharmaceutical distribution networks. Within this market, specialized ophthalmic products from EyeKare Kilitch require controlled manufacturing, appropriate formulations and dependable supply. Non-steroidal anti-inflammatory ophthalmic products are one category used in professional eye-care settings, making specialized products such as Nepafenac relevant to healthcare procurement and portfolio planning.
EyeKare Kilitch is focused on ophthalmology and lists NEPEYE OD as Nepafenac Ophthalmic Suspension IP 0.3% w/v, identified as a sterile ophthalmic suspension. For organizations researching Nepafenac Eye Drops in Pune, the product provides a clearly identified Nepafenac formulation within EyeKare’s ophthalmic portfolio.
Nepafenac is a non-steroidal anti-inflammatory drug used in ophthalmic care. Unlike conventional eye-drop descriptions that may imply a simple solution, EyeKare lists NEPEYE OD specifically as an ophthalmic suspension. Understanding the dosage form is therefore important when reviewing the product for procurement, distribution or professional use.
EyeKare’s product listing specifies Nepafenac Ophthalmic Suspension IP 0.3% w/v and identifies the formulation as sterile. This product information provides an important starting point for healthcare businesses evaluating the formulation, while the approved product information and professional guidance remain the basis for appropriate use.
NEPEYE OD is included in EyeKare Kilitch’s current ophthalmic product portfolio under the NSAID category. The listing identifies its generic name as Nepafenac Ophthalmic Suspension and its composition as Nepafenac Ophthalmic Suspension IP 0.3% w/v. This makes the product directly relevant to businesses looking for a specialized Nepafenac formulation.
For distributors and healthcare channels, having clearly documented product information can support procurement and product portfolio planning. The exact formulation, strength, dosage form, packaging and regulatory documentation should be reviewed before placing a product into a specific supply or healthcare channel.
Ophthalmic products are designed for application to the eye, so formulation and manufacturing controls are important considerations. A suspension differs from a solution in its physical characteristics and may require appropriate handling and instructions according to the approved product information.
For a product such as NEPEYE OD, evaluating the dosage form alongside its active ingredient and strength gives procurement teams a clearer understanding of what is being supplied. EyeKare’s product listing explicitly identifies the product as a sterile ophthalmic suspension, helping distinguish it from solution-based products in the wider ophthalmic portfolio.
EyeKare Kilitch describes itself as a specialized ophthalmic division of Kilitch Healthcare India Ltd. Its official website states that products are manufactured in-house in a facility spread across 3,50,000 square feet and compliant with international standards. The company also highlights more than 50 scientists working across research and development and quality control.
For pharmaceutical businesses evaluating an ophthalmic manufacturer, manufacturing infrastructure should be considered together with quality systems, product documentation, formulation capabilities and supply reliability. These factors are especially relevant when the product is intended for sterile ophthalmic use.
EyeKare’s product portfolio extends across multiple ophthalmic therapeutic categories, including anti-glaucoma, lubricants, anti-allergic products, antibiotics, antibiotic combinations, NSAIDs and other eye-care formulations. This breadth allows distributors and healthcare businesses to assess a specialist ophthalmic supplier across more than one product requirement.
The presence of NEPEYE OD in the EyeKare product portfolio within the NSAID category gives the portfolio a dedicated Nepafenac option. Businesses that handle ophthalmic products can compare it with other products in the range according to their procurement needs, market requirements and professional product specifications.
Review the Active Ingredient and Strength
The first step is to confirm the active ingredient and strength against the approved product documentation. EyeKare lists NEPEYE OD as Nepafenac Ophthalmic Suspension IP 0.3% w/v, providing a specific formulation reference for evaluation.
Check the Dosage Form
Because NEPEYE OD is listed as an ophthalmic suspension, businesses should review the applicable product information for storage, handling, administration and other requirements. Product characteristics should not be assumed from the term eye drops alone.
Evaluate Manufacturing Capabilities
A suitable manufacturer should be reviewed for production infrastructure, quality controls, documentation and supply capabilities. For sterile ophthalmic products, these considerations form an important part of supplier evaluation.
Pune’s healthcare ecosystem includes multi-specialty hospitals, ophthalmology clinics, pharmacies and pharmaceutical distribution businesses. For these channels, access to specialized ophthalmic products can support more focused procurement strategies. A dedicated Nepafenac product can be considered when the formulation matches the requirements of the relevant healthcare channel.
EyeKare’s ophthalmology specialization provides a focused product environment for businesses seeking ophthalmic formulations. Its portfolio includes NEPEYE OD alongside products across other therapeutic categories, allowing procurement teams to evaluate a broader eye-care range from a specialist supplier.
EyeKare Kilitch combines an ophthalmology-focused portfolio with in-house ophthalmic manufacturing and stated quality and research capabilities. NEPEYE OD gives the portfolio a clearly identified Nepafenac ophthalmic suspension, while the wider product range covers multiple ophthalmic categories.
Organizations can review the EyeKare product portfolio to understand NEPEYE OD and the company’s wider ophthalmic range. This can help distributors and healthcare businesses compare product categories and identify formulations that align with their procurement requirements.
Selecting an ophthalmic supplier involves more than identifying an active ingredient. Businesses should consider the dosage form, strength, sterility, manufacturing environment, quality systems, product documentation, packaging and supply capabilities. Reviewing these factors together can support a more informed procurement decision.
EyeKare’s stated commitment to ophthalmology, in-house manufacturing and product development provides relevant factors for businesses assessing a specialized ophthalmic supplier. The company’s portfolio approach also allows organizations to evaluate multiple eye-care categories through one focused platform.
Nepafenac is an established NSAID option within ophthalmic care, and EyeKare Kilitch lists NEPEYE OD as Nepafenac Ophthalmic Suspension IP 0.3% w/v and a sterile ophthalmic suspension. This gives healthcare businesses a clearly defined Nepafenac product to evaluate within a specialized ophthalmic portfolio.
For businesses searching for Nepafenac Eye Drops in Pune, EyeKare Kilitch offers a specialized ophthalmic product supported by its broader eye-care portfolio and in-house manufacturing approach. Product selection should be based on approved product information, professional requirements and applicable regulatory considerations.
Subscribe to the EyeCare newsletter to receive updates on the latest developments, events and innovations in ophthalmology.
EyeKare Kilitch is an innovative pharmaceutical company that discovers, develop, manufactures and market a broad range of healthcare products.
902-B, Godrej Coliseum, Behind Everard Nagar, Off. Eastern Express Highway, Nr. Priyadarshani Circle, Sion (E.), Mumbai - 400 022. INDIA.
© Copyright 2024 – EyeKareKilitch